Krag, Aleksander http://orcid.org/0000-0002-9598-4932
Rinella, Mary E. http://orcid.org/0000-0003-0620-9705
Article History
First Online: 7 September 2023
Competing interests
: A.K. has served as speaker for Novo Nordisk, Norgine, Siemens and Nordic Bioscience; and participated in advisory boards for Norgine, Siemens, Resalis Therapeutics, Boehringer Ingelheim and Novo Nordisk, all outside the submitted work. A.K. acknowledges research support from Norgine, Siemens, Nordic Bioscience, Astra, Echosens. Consulting Takeda, Resalis Therapeutics, Zealand Pharma, Novo Nordisk and Boehringer Ingelheim; and is a board member and co-founder of Evido. M.E.R. serves as a scientific consultant to Novo Nordisk, Boehringer Ingelheim, Intercept, CytoDyne, Histoindex, NGM Bio, GSK and Madrigal.